Utilizing Targeted Gene Editing to Engineer Durable T-Cell Therapies
- Identifying the biological process behind T-cell downregulation
- Identifying and targeting negative regulators of T-cell function to disrupt biological downregulation pathways and preserve potency
- Applying gene editing strategies to intrinsically enhance T-cell durability by preventing functional exhaustion and loss of therapeutic activity